Lv11
60 积分 2021-10-21 加入
New promises and challenges in the treatment of advanced non-small-cell lung cancer
11小时前
待确认
HER2‐positive gastric cancer with concomitant MET and/or EGFR overexpression: A distinct subset of patients for dual inhibition therapy
14天前
已完结
Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management
2个月前
已完结
Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization
4个月前
已完结
Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non–Small-Cell Lung Cancer
5个月前
已完结
Targeting the EGFR signalling pathway in metastatic colorectal cancer
5个月前
已完结
Current management of uncommon EGFR mutations in non-small cell lung cancer
7个月前
已完结
Biomarkers for monoclonal antibody targeting EGFR in NSCLC: Challenges, current status, and future perspectives
8个月前
已关闭
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
8个月前
已完结
Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti–Programmed Cell Death‐1 in HCC
9个月前
已完结
皖公网安备34019202002308
